Aeternitas Pharmaceuticals Private Limited, a active private limited company, was established on 29 September 2018 in Hyderabd, Telangana, India. Engaging in health & beauty retail & distribution within the trade sector, it holds CIN: U24100TG2018PTC127249. Registered under ROC Roc Hyderabad. it is unlisted. It has an authorized capital of ₹1.00 M and a paid-up capital of ₹1.00 M.
Its leadership includes Sarada Lakshmi Gudipati (Director), Dronamraju Prabhu (Director). Past directors included Nukala Sitaramam, Krishna Vikas Peddibhotla. Its latest AGM occurred on 30 September 2024, with the balance sheet filed on 31 March 2024. It is based at D. No. 265D, Road No.10, Jubilee Hills,, Hyderabd, Telangana, 500033.
U24100TG2018PTC127249
127249
29 September 2018
₹1.00 M
₹1.00 M
Roc Hyderabad
Unlisted
Active
Explore comprehensive insights into Aeternitas Pharmaceuticals Private Limited — covering financial performance, compliance records, Competitor, shareholding patterns, directors, key metrics, and litigation history. Unlock to see detailed insights and stay informed.
Access Report
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sarada Lakshmi Gudipati | Director | 30 Jan 2020 | Current |
| Dronamraju Prabhu | Director | 29 Sep 2018 | Current |
| Name | Designation | Cessation | Status |
|---|---|---|---|
| Pramod Abcsdd | Director | 30 Jan 2020 | Past |
| Pramod Abcsdd | Director | 30 Jan 2020 | Past |
Discover detailed profiles of directors and KMP - Unlock leadership insights today!
Aeternitas Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 142.16% increase. The company also saw a substantial improvement in profitability, with a 195.49% increase in profit. The company's net worth Soared by an impressive increase of 157.02%.
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
In 2021, Aeternitas Pharmaceuticals had a promoter holding of 46.00% and a public holding of 54.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Reveal ownership structures and financial performance - Get instant access now!
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Aeternitas Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Aeternitas Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Aeternitas Pharmaceuticals's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
The activity Aeternitas Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2024 as per latest MCA records. was completed.
The activity Aeternitas Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Hyderabad. was completed.
Progress on Sarada Lakshmi Gudipati was appointed as a Director was appointed as a Director on 30 Jan 2020 & has been associated with this company since 5 years 10 months . was documented.
The activity Dronamraju Prabhu was appointed as a Director was appointed as a Director on 29 Sep 2018 & has been associated with this company since 7 years 2 months . was completed.
Aeternitas Pharmaceuticals Private Limited was registered on 29 Sep 2018 with Roc Hyderabad & aged 7 years 2 months as per MCA records. was recorded as a recent event.
The CIN of Aeternitas Pharmaceuticals Private Limited is U24100TG2018PTC127249.
Aeternitas Pharmaceuticals Private Limited is headquartered at D. No. 265D, Road No.10, Jubilee Hills,, Hyderabd, Telangana, 500033.
Aeternitas Pharmaceuticals Private Limited was incorporated on 29 September 2018.
The current directors of Aeternitas Pharmaceuticals Private Limited are
The primary industry of Aeternitas Pharmaceuticals Private Limited is Trade.
Aeternitas Pharmaceuticals Private Limited is unlisted.
The authorized capital of Aeternitas Pharmaceuticals Private Limited is ₹1.00 M, and the paid-up capital is ₹1.00 M.
Search company & director profiles for free and gain access to critical business data.
Company Details
+91-XXXXXXXXXX